Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
CapeOX
Description:
A chemotherapy regimen combining capecitabine and oxaliplatin, used to treat colorectal and other cancers.
Primary topic:
Colorectal Cancer Treatments and Studies (40%)
Related topics:
Colorectal Cancer Treatments and Studies (40%),
Colorectal Cancer Surgical Treatments (25%),
Gastric Cancer Management and Outcomes (15%)
OpenAlex ID:
keywords/capeox
Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE Study
2008
·
Howard S. Hochster
, Lowell L. Hart
, et al.
·
Journal of Clinical Oncology
·
660
Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management
2015
·
J. Joshua Smith
, Oliver S. Chow
, et al.
·
BMC Cancer
·
413
PDF
Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial.
2020
·
Julio Garcia-Aguilar
, Sujata Patil
, et al.
·
Journal of Clinical Oncology
·
234
Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial
2021
·
Yukihide Kanemitsu
, Kohei Shitara
, et al.
·
Journal of Clinical Oncology
·
212
Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study
2023
·
Gong Chen
, Ying Jin
, et al.
·
The Lancet. Gastroenterology & hepatology
·
163
Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial
2022
·
Tomoko Yamazaki
, Andrew J Gunderson
, et al.
·
The Lancet Oncology
·
160
Safety and efficacy of oxaliplatin/fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer (mCRC): Final analysis of the TREE-Study
2006
·
H. S. Hochster
, L. L. Hart
, et al.
·
Journal of Clinical Oncology
·
154
Induction chemotherapy with capecitabine and oxaliplatin followed by chemoradiotherapy before total mesorectal excision in patients with locally advanced rectal cancer
2012
·
J.V. Schou
, F.O. Larsen
, et al.
·
Annals of Oncology
·
121
PDF
S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer (TRICOLORE): a randomized, open-label, phase III, noninferiority trial
2017
·
Y. Yamada
, T. Denda
, et al.
·
Annals of Oncology
·
100
PDF
Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer
2013
·
M.K. Boisen
, J.S. Johansen
, et al.
·
Annals of Oncology
·
92
PDF
Alterations in intestinal microbiota of colorectal cancer patients receiving radical surgery combined with adjuvant CapeOx therapy
2019
·
Cheng Kong
, Renyuan Gao
, et al.
·
Science China Life Sciences
·
79
Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial
2020
·
Haiping Jiang
, Yulong Zheng
, et al.
·
BMC Cancer
·
63
PDF
Minimal Residual Disease–Directed Adjuvant Therapy for Patients With Early-Stage Colon Cancer: CIRCULATE-US
2022
·
Sahin,Ibrahim;Lin,Yan;Yothers,Greg;Lucas,Peter;Deming,Dustin;George,Thomas;Kopetz,Scott;Lieu,Christopher;Dasari,Arvind;
, Yan Lin
, et al.
·
ONCOLOGY
·
55
Effects of Proton Pump Inhibitors on FOLFOX and CapeOx Regimens in Colorectal Cancer
2018
·
Grace G. Wong
, Vincent Ha
, et al.
·
Clinical Colorectal Cancer
·
52
Proton pump inhibitors increase the chemosensitivity of patients with advanced colorectal cancer
2017
·
Xiaoyu Wang
, Chun Liu
, et al.
·
Oncotarget
·
49
PDF
Tissue MicroRNAs as Predictors of Outcome in Patients with Metastatic Colorectal Cancer Treated with First Line Capecitabine and Oxaliplatin with or without Bevacizumab
2014
·
Mogens K. Boisen
, Christian Dehlendorff
, et al.
·
PLoS ONE
·
46
PDF
Real-World Outcomes of Patients With BRAF-Mutated Metastatic Colorectal Cancer Treated in the United States
2022
·
Andrew Trunk
, Matthew Braithwaite
, et al.
·
Journal of the National Comprehensive Cancer Network
·
43
PDF
Adjuvant Chemotherapy for Locally Advanced Rectal Cancer: Is It a Given?
2015
·
Theodore S. Hong
, David P. Ryan
·
Journal of Clinical Oncology
·
40
Survival and organ preservation according to clinical response after total neoadjuvant therapy in locally advanced rectal cancer patients: A secondary analysis from the organ preservation in rectal adenocarcinoma (OPRA) trial.
2021
·
Hannah Thompson
, Jin Ki Kim
, et al.
·
Journal of Clinical Oncology
·
37
Prophylactic efficacy of ninjin’yoeito for oxaliplatin-induced cumulative peripheral neuropathy in patients with colorectal cancer receiving postoperative adjuvant chemotherapy: a randomized, open-label, phase 2 trial (HOPE-2)
2020
·
Yoshiharu Motoo
, Yasuto Tomita
, et al.
·
International Journal of Clinical Oncology
·
36
Optimizing Adjuvant Therapy for Localized Colon Cancer and Treatment Selection in Advanced Colorectal Cancer
2018
·
Axel Grothey
, Alan P. Venook
·
Journal of the National Comprehensive Cancer Network
·
31
PDF
Management of advanced colorectal cancer, part 1
2013
·
Robert J. Cersosimo
·
American Journal of Health-System Pharmacy
·
31
A randomized phase III trial comparing primary tumor resection plus chemotherapy with chemotherapy alone in incurable stage IV colorectal cancer: JCOG1007 study (iPACS).
2020
·
Yukihide Kanemitsu
, Kohei Shitara
, et al.
·
Journal of Clinical Oncology
·
29
Selecting a TNT Schedule in Locally Advanced Rectal Cancer: Can We Predict Who Actually Benefits?
2023
·
Carlo Aschele
, Robert Glynne-Jones
·
Cancers
·
28
PDF
S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial
2014
·
Seung Tae Kim
, Yong Sang Hong
, et al.
·
BMC Cancer
·
26
PDF
Show more works
View as search
Works count:
467
Citation count:
4,114
Year
Topic
Type